Winter 2024-2025
March 14, 2025
Myeloma Center Focuses on Immunotherapy Drugs in Latest Clinical Trials
Multiple myeloma treatment is advancing with the advent of bispecific antibody drugs, which use the patient’s T cells to fight the disease. Myeloma Center physicians and researchers Carolina Schinke, M.D., and Samer Al Hadidi, M.D., M.S., are leading clinical trials exploring combinations of these novel therapies. Schinke’s trial is studying the effects of using teclistamab…
Nurse Inspired to Serve by Memory of Grandparent’s Health Struggles
Christina Ketchum, MSN, clinical services manager for myeloma stem cell transplants at the University of Arkansas for Medical Sciences (UAMS), cites a childhood memory as her inspiration to become a nurse. “My grandfather was at home on hospice care,” Ketchum said. “I was in fourth or fifth grade at the time and didn’t fully understand…
From The Clinical Director
It is my great pleasure to present the Winter 2024-25 issue of the Myeloma magazine. As we celebrate 35 years of myeloma care at the University of Arkansas for Medical Sciences (UAMS), we look forward to the future. The increased use of novel immunotherapies, which are highly effective and less toxic, are a significant advancement…
From The Director
Welcome to the latest issue of the Myeloma magazine as we celebrate 35 years of outstanding patient care and leading-edge research. The Myeloma Center is a vital component of the exceptional treatment provided at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). Since my arrival in 2019, I…
Previous page